Download presentation
Presentation is loading. Please wait.
Published byBruno Alexander Modified over 6 years ago
1
Presented By James Hill at 2016 ASCO Annual Meeting
The CREST Trial Presented By James Hill at 2016 ASCO Annual Meeting
2
Learning Objectives for obstructing colorectal cancer
Presented By James Hill at 2016 ASCO Annual Meeting
3
Rationale of CREST – Converting emergency into elective surgery
Presented By James Hill at 2016 ASCO Annual Meeting
4
Presented By James Hill at 2016 ASCO Annual Meeting
Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Endoscopy 2014; 46: 990–1002 Presented By James Hill at 2016 ASCO Annual Meeting
5
CREST – Primary Objectives
Presented By James Hill at 2016 ASCO Annual Meeting
6
CREST – Secondary outcome measures
Presented By James Hill at 2016 ASCO Annual Meeting
7
Presented By James Hill at 2016 ASCO Annual Meeting
The CREST Trial Design Presented By James Hill at 2016 ASCO Annual Meeting
8
CREST – Eligibility Criteria
Presented By James Hill at 2016 ASCO Annual Meeting
9
Compliance with Randomised Treatment Allocation
Presented By James Hill at 2016 ASCO Annual Meeting
10
CREST Patient Demographics
Presented By James Hill at 2016 ASCO Annual Meeting
11
CREST Patient Baseline Data
Presented By James Hill at 2016 ASCO Annual Meeting
12
CREST Patient Baseline Data - Stratification
Presented By James Hill at 2016 ASCO Annual Meeting
13
Does stenting reduce length of stay and 30-day mortality?
Presented By James Hill at 2016 ASCO Annual Meeting
14
Stenting Completion and Immediate Complication Rate
Presented By James Hill at 2016 ASCO Annual Meeting
15
Stenting Intermediate and Late Complication Rates
Presented By James Hill at 2016 ASCO Annual Meeting
16
Stent related perforations
Presented By James Hill at 2016 ASCO Annual Meeting
17
Does stenting reduce stoma rates?
Presented By James Hill at 2016 ASCO Annual Meeting
18
Presented By James Hill at 2016 ASCO Annual Meeting
6-Month Survival Rates Presented By James Hill at 2016 ASCO Annual Meeting
19
Severity of Surgical Complications (Clavien-Dindo Classification)
Presented By James Hill at 2016 ASCO Annual Meeting
20
Presented By James Hill at 2016 ASCO Annual Meeting
Summary Presented By James Hill at 2016 ASCO Annual Meeting
21
Conclusions – SEMS as a bridge to surgery
Presented By James Hill at 2016 ASCO Annual Meeting
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.